Detalhe da pesquisa
1.
Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis.
Leuk Lymphoma
; 60(4): 1036-1042, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30234400
2.
Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics.
Clin Lymphoma Myeloma Leuk
; 18(5): e201-e210, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29574002
3.
Profile of pomalidomide and its potential in the treatment of myelofibrosis.
Ther Clin Risk Manag
; 11: 549-56, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25897239